Investor Relations
Developing Novel Therapeutics to Destroy Cancer
Corporate Overview
BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. More information is available at https://briacell.com/.
Change
Volume
52 Weeks
-
Day
-
Change
Volume
52 Weeks
-
Day
-
Latest News
Corporate Office - Canada
Suite 300 - Bellevue Centre, 235 -15th Street,
West Vancouver, BC V7T 2X1
Tel: 604-921-1810
Fax: 604-921-1898
Corporate Office - USA
2929 Arch Street, 3rd Floor
Philadelphia, PA 19104
Tel: 1-888-485-6340
Fax: 424-245-3719
Copyright 2024 © BriaCell Therapeutics Corp. | All rights reserved | XML Sitemap | HTML Sitemap | Powered by Issuer Direct